English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing Journal article
Zhou, Yan, Guo, Yizhen, Ran, Maoxin, Shan, Wenying, Granchi, Carlotta, Giovannetti, Elisa, Minutolo, Filippo, Peters, Godefridus J., Tam, Kin Yip. Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing[J]. Cancer Letters, 2023, 577, 216425.
Authors:  Zhou, Yan;  Guo, Yizhen;  Ran, Maoxin;  Shan, Wenying;  Granchi, Carlotta; et al.
Favorite | TC[WOS]:10 TC[Scopus]:7  IF:9.1/8.3 | Submit date：2023/12/04
Anticancer  Combination Treatment  Non-small Cell Lung Cancer  Warburg Effect  
Recent advances in organotypic tissue slice cultures for anticancer drug development Review article
2022
Authors:  He, Lin;  Deng, Chuxia
Favorite | TC[WOS]:16 TC[Scopus]:17  IF:8.2/8.3 | Submit date：2023/01/30
Anticancer Drug Discovery  Individualized Treatment  Organotypic Tissue Slice Culture  Precision Oncology  
Development of dichloroacetamide pyrimidine derivatives as pyruvate dehydrogenases kinase inhibitor to reduce cancer cell growth: synthesis and biological evaluation Journal article
Zhang, S., Zhang, W., Xiao, Q., Yang, Z., Hu, X., Wei, Z., Tam, K. Y.. Development of dichloroacetamide pyrimidine derivatives as pyruvate dehydrogenases kinase inhibitor to reduce cancer cell growth: synthesis and biological evaluation[J]. RSC Advances, 2016, 78762-78767.
Authors:  Zhang, S.;  Zhang, W.;  Xiao, Q.;  Yang, Z.;  Hu, X.; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5  IF:3.9/3.9 | Submit date：2022/07/28
Pyruvate Dehydrogenases Kinase Inhibitors  Anticancer Treatment